Neuromelanin or DaT‐SPECT: which is the better marker for discriminating advanced Parkinson's disease?

BACKGROUND AND PURPOSE: Whether the neuromelanin‐positive substantia nigra pars compacta area (NM‐SNc) on neuromelanin magnetic resonance imaging (NM‐MRI) and the specific binding ratio (SBR) on (123)I‐N‐v‐fluoropropyl‐2b‐carbomethoxy3b‐(4‐iodophenyl)nortropane single photon emission computed tomogr...

Descripción completa

Detalles Bibliográficos
Autores principales: Okuzumi, A., Hatano, T., Kamagata, K., Hori, M., Mori, A., Oji, Y., Taniguchi, D., Daida, K., Shimo, Y., Yanagisawa, N., Nojiri, S., Aoki, S., Hattori, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851628/
https://www.ncbi.nlm.nih.gov/pubmed/31136060
http://dx.doi.org/10.1111/ene.14009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851628/
https://www.ncbi.nlm.nih.gov/pubmed/31136060
http://dx.doi.org/10.1111/ene.14009

Ejemplares similares